Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioplus Acquisition Corp Cl A (NQ: BIOS ) N/A UNCHANGED Last Price Updated: 3:46 PM EDT, Oct 6, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 10.70 (3) Ask (Size) 10.80 (3) Prev. Close 10.79 Today's Range N/A - N/A 52wk Range 10.78 - 10.84 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination October 04, 2023 From Avertix Medical Inc. Via GlobeNewswire BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate October 04, 2023 From BioPlus Acquisition Corp. Via GlobeNewswire Performance More News Read More Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring August 16, 2023 From Avertix Medical Inc. Via GlobeNewswire Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors July 17, 2023 From Avertix Medical Inc. Via GlobeNewswire Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando June 13, 2023 From Avertix Medical Inc. Via GlobeNewswire Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation May 03, 2023 From Avertix Medical Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.